comparemela.com

Latest Breaking News On - Elizabeth mannheimer - Page 1 : comparemela.com

Insightec Announces FDA Approval of Exablate Neuro for the Treatment of Parkinson s Disease

Insightec Announces Samsung Medical Center Is Joining Focused Ultrasound Community

Insightec Announces Samsung Medical Center Is Joining Focused Ultrasound Community News provided by Share this article Share this article The program offers treatment for patients with Movement Disorders, pain, and behavioral disorders in South Korea HAIFA, Israel and MIAMI, July 5, 2021 /PRNewswire/  Insightec®, a global healthcare company focused on creating the next generation of patient care, announced Samsung Medical Center is establishing a Focused Ultrasound program with the adoption of Exablate® Neuro. The Exablate Neuro (Exablate 4000) platform uses Focused Ultrasound to ablate targets deep in the brain for a therapeutic effect.   Leading neuroscience departments at medical centers around the globe recognize the value of adopting Focused Ultrasound as a treatment option for patient care, commented Ori Atar, Director of Asia Growth Markets at Insightec. We are excited by the growth of adoption in the Korean market.

Insightec Announces Registration Approval Of Exablate Neuro By Singapore Health Sciences Authority

Insightec Announces Registration Approval Of Exablate Neuro By Singapore Health Sciences Authority News provided by Share this article Share this article Positive momentum continues to bring Focused Ultrasound to global patients living with Essential Tremor and Tremor-dominant Parkinson s Disease HAIFA, Israel and MIAMI, July 5, 2021 /PRNewswire/  Insightec®, a global healthcare company focused on creating the next generation of patient care, announced approval of the Exablate® Neuro platform by the Health Sciences Authority (HSA) in Singapore. The Exablate Neuro (Exablate 4000) platform uses Focused Ultrasound to ablate a target deep in the brain. The unilateral treatment is suitable for patients with Essential Tremor (age 22 or older) or Tremor-dominant Parkinson s Disease (age 30 or older) who have not responded to medications.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.